Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Squamous Cell Carcinoma of Head and Neck 1Neoplasms 1Laryngeal Neoplasms 1Laryngeal Diseases 1

Interventions

Cisplatin 620pembrolizumab 323Radiotherapy 319Cetuximab 275Docetaxel 221Radiotherapy, Intensity-Modulated 210Carboplatin 197Fluorouracil 196Paclitaxel 159Nivolumab 138Gemcitabine 124Magnetic Resonance Spectroscopy 94Radiation 85Drug Therapy 77Capecitabine 76toripalimab 75Surgical Procedures, Operative 63durvalumab 60Biopsy 52Cyclophosphamide 50Chemoradiotherapy 47camrelizumab 46Specimen Handling 46Erlotinib Hydrochloride 46Radiosurgery 45130-nm albumin-bound paclitaxel 44Standard of Care 43tislelizumab 42Platinum 41Bevacizumab 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Laryngectomy × Head & Neck × Clear all
NCT07392580 2026-06-01

Intralesional Chemotherapy (IC): Cisplatin + Epinephrine

University of Miami

Phase 2 Recruiting
20 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00128817 2013-01-23

Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers

Tata Memorial Hospital

Phase 3 Terminated
900 enrolled
Head & Neck

Laryngeal Diseases, Laryngeal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡